CoChat

PHARMACOTHERAPIES FOR ALCOHOL ABUSE

Open access
Saitz, Richard, O'Malley, Stephanie S. · 1997 · Medical Clinics of North America
Cited by 129

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Pharmacologic management of alcoholism is only one part of the management of both alcohol dependence and withdrawal, which also includes the provision of a calm, quiet environment; reassurance; ongoing reassessment; attention to fluid and electrolyte disorders; treatment of coexisting addictions and common medical, surgical, and psychiatric comorbidities; and referral for ongoing psychosocial and medical treatment. For further discussion of these topics, the reader is referred to previously published sources. A survey of alcoholism treatment programs revealed that although benzodiazepines were the most commonly used drugs, standardized monitoring of patients' withdrawal severity was not common practice, and a significant minority of clinicians were using a variety of other drugs, some not known to prevent or treat the complications of withdrawal. Treatment should be based on the available evidence (Working Group on Pharmacological Management of Alcohol Withdrawal: American Society of Addiction Medicine Committee on Practice Guidelines: Pharmacological management of alcohol withdrawal: An evidence-based practice guideline. Unpublished draft, 1997). Patients with significant symptoms, patients with complications such as seizures or delirium tremens, and patients at higher risk for complications of alcohol withdrawal should receive benzodiazepines, particularly chlordiazepoxide, diazepam, or lorazepam, because of their safety and documented efficacy in preventing and treating the most serious complications of alcohol withdrawal. These drugs may be dosed on a fixed schedule for a predetermined number of doses on a tapering schedule over several days, or they may be administered by front-loading. An alternative approach for selected patients without seizures or acute comorbidity is symptom-triggered therapy, which individualizes treatment and decreases the duration and dose of medication administration. With either of the regimens, patients should have their withdrawal severity monitored until symptoms are resolving. Once withdrawal from alcohol is safely completed, the focus should turn to helping to prevent relapse. Disulfiram may be useful in highly motivated subsets of patients and when compliance-enhancing strategies are used. Naltrexone is useful in the broader population of patients entering treatment for alcohol dependence. These pharmacologic interventions should be given in the context of ongoing psychosocial support. There is substantial evidence that pharmacologic management of alcohol abuse and dependence is effective. As would be predicted from alcohol's myriad cellular effects, no panacea exists for alcoholism. For alcohol withdrawal, however, although treatment regimens have only recently been refined, evidence for effective treatment of symptoms and prevention of complications with benzodiazepines has been available for decades. Within the last decade, effective treatments, including naltrexone, have been shown to reduce alcohol intake in alcohol-dependent persons. Given the prevalence and cost of alcohol-related problems, all effective therapies (including pharmacologic treatments) should be considered to treat alcohol abuse and dependence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0025-7125(05)70554-x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 150

  1. Allan, 1987, Involvement of neuronal chloride channels in ethanol intoxication, tolerance, and dependence, 313, 10.1007/978-1-4899-1684-6_12 · DOI
  2. Alldredge, 1993, Status epilepticus related to alcohol abuse, Epilepsia, 34, 1033, 10.1111/j.1528-1157.1993.tb02130.x · DOI · Paper page
  3. Alldredge, 1989, Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures, Am J Med, 87, 645, 10.1016/S0002-9343(89)80397-3 · DOI
  4. Annis, 1991, A cognitive-social learning approach to relapse: Pharmacotherapy and relapse prevention counseling, Alcohol Alcohol, 527
  5. Baekeland, 1971, Correlates of outcome in disulfiram treatment of alcoholism, J Nerv Ment Dis, 153, 1, 10.1097/00005053-197107000-00001 · DOI · Paper page
  6. Banki, 1983, Comparative study with grandaxin and diazepam in alcohol withdrawal syndrome and gerontopsychiatric diseases, Ther Hung, 31, 120
  7. Baumgartner, 1987, Clonidine versus chlordiazepoxide in the management of the acute alcohol withdrawal syndrome, Arch Intern Med, 147, 1223, 10.1001/archinte.1987.00370070037005 · doi:10.1001/archinte.1987.00370070037005 · Paper page
  8. Benzer, 1990, Quantification of the alcohol withdrawal syndrome in 487 alcoholic patients, J Subst Abuse Treat, 7, 117, 10.1016/0740-5472(90)90007-D · DOI
  9. Bezzegh, 1991, Alpha-atrial natriuretic peptide, aldosterone secretion and plasma renin activity during alcohol withdrawal: A correlation with the onset of delirium tremens?, Alcohol, 8, 333, 10.1016/0741-8329(91)90513-V · DOI
  10. Bjorkqvist, 1975, Clonidine in alcohol withdrawal, Acta Psychiatr Scand, 52, 256, 10.1111/j.1600-0447.1975.tb00041.x · DOI · Paper page
  11. Bjorkvist, 1976, Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: A formal multicentre double-blind comparison with placebo, Acta Psychiatr Scand, 53, 333, 10.1111/j.1600-0447.1976.tb00081.x · DOI · Paper page
  12. Booth, 1993, The kindling hypothesis: Further evidence from a U.S. national study of alcoholic men, Alcohol Alcohol, 28, 593
  13. Bowman, 1966, Treatment of alcoholism in the subacute stage: A study of three active agents, Dis Nerv Syst, 27, 342
  14. Brewer, 1984, How effective is the standard dose of disulfiram? A review of the alcohol-disulfiram reaction in practice, Br J Psychiatry, 144, 200, 10.1192/bjp.144.2.200 · DOI · Paper page
  15. Brower, 1994, Severity and treatment of alcohol withdrawal in elderly versus younger patients, Alcohol Clin Exp Res, 18, 196, 10.1111/j.1530-0277.1994.tb00903.x · DOI · Paper page
  16. Brown, 1988, Alcohol detoxification and withdrawal seizures: Clinical support for a kindling hypothesis, Biol Psychiatry, 23, 507, 10.1016/0006-3223(88)90023-6 · DOI · Paper page
  17. Buchsbaum, 1991, Screening for alcohol abuse using CAGE scores and likelihood ratios, Ann Intern Med, 115, 774, 10.7326/0003-4819-115-10-774 · DOI · Paper page
  18. Buchsbaum, 1991, Alcohol consumption patterns in a primary care population, Alcohol Alcohol, 26, 215, 10.1093/oxfordjournals.alcalc.a045103 · DOI
  19. Buchsbaum, 1992, Physician detection of drinking problems in patients attending a general medicine practice, J Gen Intern Med, 7, 517, 10.1007/BF02599456 · DOI
  20. Burroughs, 1985, Double-blind controlled trial of bromocriptine, chlordiazepoxide and chlormethiazole for alcohol withdrawal symptoms, Alcohol Alcohol, 20, 263
  21. Chambers, 1965, Double-blind study of three drugs in the treatment of acute alcoholic states, Q J Stud Alcohol, 26, 10, 10.15288/qjsa.1965.26.010 · DOI
  22. Chance, 1991, Emergency department treatment of alcohol withdrawal seizures with phenytoin, Ann Emerg Med, 20, 520, 10.1016/S0196-0644(05)81606-3 · DOI
  23. Chu, 1979, Carbamazepine: Prevention of alcohol withdrawal seizures, Neurology, 29, 1397, 10.1212/WNL.29.10.1397 · DOI · Paper page
  24. Ciraulo, 1981, Imipramine disposition in alcoholics, J Clin Psychopharmacol, 68, 819
  25. Clothier, 1985, Varying rates of alcohol metabolism in relation to detoxification medication, Alcohol, 2, 443, 10.1016/0741-8329(85)90112-0 · doi:10.1016/0741-8329(85)90112-0
  26. Cornelius, 1993, Fluoxetine trial in suicidal depressed alcoholics, Psychopharmacol Bull, 29, 195
  27. Croop RS, Labriola DF, Wroblewski JM, et al: A multicenter safety study of naltrexone as adjunctive pharmacotherapy for individuals with alcoholism. Presented at Annual Meeting of the American Psychiatric Association, Miami, 1995 · doi:10.1016/0924-977x(95)90742-v
  28. Daoust, 1992, Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats, Pharmacol Biochem Behav, 41, 669, 10.1016/0091-3057(92)90210-7 · DOI
  29. Daryanani, 1994, Alcoholic withdrawal syndrome and seizures, Alcohol Alcohol, 29, 323
  30. D'Onofrio, 1995, Lorazepam prevents recurrent alcohol-related seizures [abstr], Acad Emerg Med, 2, 368
  31. Engle, 1972, Effect of an ounce of vodka on alcoholics' desire for alcohol, Q J Stud Alcohol, 33, 1099, 10.15288/qjsa.1972.33.1099 · DOI · Paper page
  32. Farren C, O'Malley SS, Rounsaville BJ: Naltrexone and opiate abuse: Who benefits from it and how to increase its effectiveness. In Stine S, Kosten T (eds): New Treatments for Opiate Dependence: Which Treatments for Which Patients. New York, Guildford Press, in press
  33. Ferguson, 1996, Risk factors for delirium tremens development, J Gen Intern Med, 11, 410, 10.1007/BF02600188 · DOI · Paper page
  34. Foy, 1988, Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital, Alcohol Clin Exp Res, 12, 360, 10.1111/j.1530-0277.1988.tb00208.x · DOI · Paper page
  35. Gerra, 1992, Effects of fluoxetine and CA-acetyl-homotaurinate on alcohol intake in familial and non-familial alcoholic patients, Curr Ther Res, 52, 291, 10.1016/S0011-393X(05)80480-1 · DOI
  36. Golbert, 1967, Comparative evaluation of treatments of alcohol withdrawal syndromes, JAMA, 201, 113, 10.1001/jama.1967.03130020045009 · DOI · Paper page
  37. Gold, 1980, Opiate withdrawal using clonidine, JAMA, 243, 343, 10.1001/jama.1980.03300300021018 · doi:10.1001/jama.1980.03300300021018 · Paper page
  38. Gordis, 1996, Alcohol research: At the cutting edge, Arch Gen Psychiatry, 53, 199, 10.1001/archpsyc.1996.01830030017004 · doi:10.1001/archpsyc.1996.01830030017004
  39. Grant, 1994, Alcohol consumption, alcohol abuse and alcohol dependence: The United States as an example, Addiction, 89, 1357, 10.1111/j.1360-0443.1994.tb03730.x · DOI
  40. Greenblatt, 1983, Current status of benzodiazepines, N Engl J Med, 309, 410, 10.1056/NEJM198308183090705 · DOI · Paper page
  41. Griffiths, 1990, Relative abuse potential of different benzodiazepines in drug abusers, J Clin Psychopharmacol, 10, 237, 10.1097/00004714-199008000-00002 · DOI · Paper page
  42. Harper, 1979, Wernicke's encephalopathy: A more common disease than realized: A neuropathological study of 51 cases, J Neurol Neurosurg Psychiatry, 42, 226, 10.1136/jnnp.42.3.226 · DOI · Paper page
  43. Hatsukami, 1982, Posttreatment depression in an alcohol and drug abuse population, Am J Psychiatry, 139, 1563, 10.1176/ajp.139.12.1563 · DOI
  44. Hayashida, 1989, Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome, N Engl J Med, 320, 358, 10.1056/NEJM198902093200605 · DOI · Paper page
  45. Helzer, 1988, The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment, J Stud Alcohol, 49, 219, 10.15288/jsa.1988.49.219 · DOI · Paper page
  46. Hill, 1993, Hazards associated with the use of benzodiazepines in alcohol detoxification, J Subst Abuse Treat, 10, 449, 10.1016/0740-5472(93)90005-M · DOI
  47. Hoey, 1994, A prospective evaluation of benzodiazepine guidelines in the management of patients hospitalized for alcohol withdrawal, Pharmacotherapy, 14, 579, 10.1002/j.1875-9114.1994.tb02854.x · DOI
  48. Hyman, 1995, Current treatment for alcohol withdrawal, J Gen Intern Med, 10, 523, 10.1007/BF02602408 · doi:10.1007/bf02602408
  49. Isbell, 1955, An experimental study of the etiology of “rum fits” and delirium tremens, Q J Stud Alcohol, 16, 1, 10.15288/qjsa.1955.16.001 · DOI · Paper page
  50. Jaffe, 1996, Naltrexone, relapse prevention, and supportive therapy with alcoholics: An analysis of patient treatment matching, J Consult Clin Psychology, 64, 1044, 10.1037/0022-006X.64.5.1044 · DOI
  51. Jessup, 1987, Treatment of the pregnant alcohol-dependent woman, J Psychoactive Drugs, 19, 193, 10.1080/02791072.1987.10472403 · DOI
  52. Kaim, 1969, Treatment of the acute alcohol withdrawal state: A comparison of four drugs, Am J Psychiatry, 125, 1640, 10.1176/ajp.125.12.1640 · DOI · Paper page
  53. Kamerow, 1986, Alcohol abuse, other drug abuse and mental disorders in medical practice, JAMA, 255, 2054, 10.1001/jama.1986.03370150096035 · DOI · Paper page
  54. Kessler, 1994, Lifetime and 12-month prevalence of DSM- III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey, Arch Gen Psychiatry, 51, 8, 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
  55. Kolata, 1986, New drug counters alcohol intoxication, Science, 234, 1198, 10.1126/science.3775379 · DOI
  56. Kramp, 1978, Delirium tremens: A double-blind comparison of diazepam and barbital treatment, Acta Psychiatr Scand, 58, 174, 10.1111/j.1600-0447.1978.tb06930.x · DOI · Paper page
  57. Kranzler, 1994, Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism, J Consult Clin Psychol, 62, 1116, 10.1037/0022-006X.62.6.1116 · doi:10.1037/0022-006x.62.6.1116
  58. Kranzler, 1995, Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics, Am J Psychiatry, 152, 391, 10.1176/ajp.152.3.391 · DOI · Paper page
  59. Kraus, 1985, Randomized clinical trial of atenolol in patients with alcohol withdrawal, N Engl J Med, 313, 905, 10.1056/NEJM198510103131501 · DOI · Paper page
  60. Lake, 1977, Increased sympathetic nervous activity in alcoholic patients treated with disulfiram, Am J Psychiatry, 134, 1411, 10.1176/ajp.134.12.1411 · DOI
  61. Lechtenberg, 1991, Relative kindling effect of detoxification and non-detoxification admissions in alcoholics, Alcohol Alcohol, 26, 221, 10.1093/oxfordjournals.alcalc.a045104 · DOI · Paper page
  62. Lee, 1985, Age of onset versus duration of problem drinking on the alcohol use inventory, J Stud Alcohol, 46, 398, 10.15288/jsa.1985.46.398 · DOI
  63. Levin, 1985, The role of magnesium in cardiovascular disorders, Cardiovasc Med, 10, 37
  64. Levy, 1967, A clinical comparison of disulfiram and calcium carbimide, Am J Psychiatry, 123, 1018, 10.1176/ajp.123.8.1018 · DOI
  65. Lhuintre, 1985, Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics, Lancet, 1, 1014, 10.1016/S0140-6736(85)91615-0 · DOI · Paper page
  66. Lhuintre, 1990, Acamprosate appears to decrease alcohol intake in weaned alcoholics, Alcohol Alcohol, 25, 613, 10.1093/oxfordjournals.alcalc.a045057 · DOI · Paper page
  67. Liskow, 1987, Pharmacological treatment of alcohol intoxication, withdrawal, and dependence: A critical review, J Stud Alcohol, 48, 356, 10.15288/jsa.1987.48.356 · DOI · Paper page
  68. Liskow, 1989, Alcohol withdrawal in the elderly, J Stud Alcohol, 50, 414, 10.15288/jsa.1989.50.414 · DOI · Paper page
  69. Lister, 1987, The benzodiazepine receptor inverse agonists FG 7142 and RO 15-4513 both reverse some of the behavioral effects of ethanol in a holeboard test, Life Sci, 41, 1481, 10.1016/0024-3205(87)90713-2 · DOI
  70. Lister, 1988, Alcohol antagonists—the continuing quest, Alcohol Clin Exp Res, 12, 566, 10.1111/j.1530-0277.1988.tb00243.x · DOI
  71. Littleton, 1995, Acamprosate in alcohol dependence: How does it work?, Addiction, 90, 1179, 10.1111/j.1360-0443.1995.tb01088.x · DOI · Paper page
  72. Ludwig, 1974, The first drink: Psychobiological aspects of craving, Arch Gen Psychiatry, 30, 539, 10.1001/archpsyc.1974.01760100093015 · DOI · Paper page
  73. Lundwall, 1971, Disulfiram treatment of alcoholism, J Nerv Ment Dis, 153, 381, 10.1097/00005053-197112000-00002 · DOI · Paper page
  74. Malcolm, 1989, Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal, Am J Psychiatry, 146, 617, 10.1176/ajp.146.5.617 · DOI · Paper page
  75. Marconi, 1960, Comparative clinical study of the effects of disulfiram and calcium carbimide, Am J Psychiatry, 123, 1018
  76. Martin, 1973, Naltrexone, an antagonist for the treatment of heroin dependence: Effects in man, Arch Gen Psychiatry, 28, 784, 10.1001/archpsyc.1973.01750360022003 · DOI · Paper page
  77. Mason, 1996, A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression, JAMA, 275, 761, 10.1001/jama.1996.03530340025025 · DOI · Paper page
  78. Mason, 1994, A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence, Alcohol Clin Exp Res, 18, 1162, 10.1111/j.1530-0277.1994.tb00098.x · DOI · Paper page
  79. Mayo-Smith, 1995, Late-onset seizures in alcohol withdrawal, Alcohol Clin Exp Res, 19, 656, 10.1111/j.1530-0277.1995.tb01563.x · DOI · Paper page
  80. McClellan, 1993, The effects of psychosocial services in substance abuse treatment, JAMA, 269, 1953, 10.1001/jama.1993.03500150065028 · DOI · Paper page
  81. McLean, 1994, Magnesium and its therapeutic uses: A review, Am J Med, 96, 63, 10.1016/0002-9343(94)90117-1 · DOI · Paper page
  82. Mendels, 1985, Halazepam in the management of acute alcohol withdrawal syndrome, J Clin Psychiatry, 46, 172
  83. Mendelson, 1969, Effects of alcohol ingestion and withdrawal on magnesium states of alcoholics: Clinical and experimental findings, Ann NY Acad Sci, 162, 918, 10.1111/j.1749-6632.1969.tb13021.x · DOI
  84. Meyer, 1984, Bioequivalence, dose-proportionality and pharmacokinetics of naltrexone after oral administration, in a new approach to the management of opioid dependence, J Clin Psychiatry, 45, 15
  85. Miller, 1984, A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of acute alcohol withdrawal syndrome, Clin Ther, 6, 364
  86. Monti, 1991, Ritanserin decreases alcohol intake in chronic alcoholics, Lancet, 337, 60, 10.1016/0140-6736(91)93386-N · DOI
  87. Morse, 1992, The definition of alcoholism, JAMA, 268, 1012, 10.1001/jama.1992.03490080086030 · DOI
  88. Morton, 1994, A prediction model for identifying alcohol withdrawal seizures, Am J Drug Alcohol Abuse, 20, 75, 10.3109/00952999409084058 · DOI · Paper page
  89. Moskowitz, 1983, Deficiencies of clinical trials of alcohol withdrawal, Alcohol Clin Exp Res, 7, 42, 10.1111/j.1530-0277.1983.tb05409.x · DOI · Paper page
  90. Naranjo, 1990, Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers, Clin Pharmacol Ther, 47, 490, 10.1038/clpt.1990.62 · DOI · Paper page
  91. Naranjo, 1983, Nonpharmacologic intervention in acute alcohol withdrawal, Clin Pharmacol Ther, 34, 214, 10.1038/clpt.1983.155 · DOI · Paper page
  92. Naranjo, 1984, Zimelidine-induced variations in alcohol intake by non-depressed heavy drinkers, Clin Pharmacol Ther, 35, 374, 10.1038/clpt.1984.46 · DOI · Paper page
  93. Naranjo, 1987, The serotonin uptake inhibitor citalopram attenuates ethanol intake, Clin Pharmacol Ther, 41, 266, 10.1038/clpt.1987.27 · DOI · Paper page
  94. Nunes, 1993, Imipramine treatment of alcoholism with comorbid depression, Am J Psychiatry, 150, 963, 10.1176/ajp.150.6.963 · DOI · Paper page
  95. O'Brien, 1996, Naltrexone in the treatment of alcoholism: A clinical review, Alcohol, 13, 35, 10.1016/0741-8329(95)02038-1 · DOI · Paper page
  96. O'Brien, 1983, Double-blind comparison of lorazepam and diazepam in the treatment of the acute alcohol abstinence syndrome, Curr Ther Res, 34, 825
  97. O'Connor, 1991, Social and clinical features as predictors of outcome in outpatient alcohol withdrawal, J Gen Intern Med, 6, 312, 10.1007/BF02597427 · DOI
  98. O'Connor PG, Farren CK, Rounsaville BJ, et al: Treatment of alcohol dependence with naltrexone by primary care providers. In Harris LS (ed): Problems of Drug Dependence 1995: Proceedings of the 57th Annual Scientific Meeting, The College on Problems of Drug Dependence, Rockville, MD, National Institute on Drug Abuse, 1996, p 329
  99. O'Malley, 1995, Integration of opioid antagonists and psychosocial therapy in the treatment of alcohol and narcotic dependence, J Clin Psychiatry, 56, 30
  100. O'Malley, 1995, Naltrexone in the treatment of alcohol dependence: A combined analysis of two trials, Psychiatr Ann, 25, 681, 10.3928/0048-5713-19951101-11 · DOI
  101. O'Malley, 1996, Six month follow-up of naltrexone and psychotherapy for alcohol dependence, Arch Gen Psychiatry, 53, 217, 10.1001/archpsyc.1996.01830030039007 · DOI · Paper page
  102. O'Malley, 1992, Naltrexone and coping skills therapy for alcohol dependence: A controlled study, Arch Gen Psychiatry, 49, 881, 10.1001/archpsyc.1992.01820110045007 · DOI · Paper page
  103. O'Malley, 1996, Experience of a `slip' among alcoholics treated with naltrexone or placebo, Am J Psychiatry, 153, 281, 10.1176/ajp.153.2.281 · DOI · Paper page
  104. Paille, 1995, Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol, Alcohol Alcohol, 30, 239
  105. Pfohl, 1986, Naltrexone hydrochloride (Trexan): A review of serum transaminase elevations at high dosage
  106. Pottenger, 1978, The frequency and persistence of depressive symptoms in the alcohol abuser, J Nerv Ment Dis, 166, 562, 10.1097/00005053-197808000-00003 · DOI · Paper page
  107. Pristach, 1983, Alcohol withdrawal syndromes—prediction from detailed medical and drinking histories, Drug Alcohol Depend, 11, 177, 10.1016/0376-8716(83)90078-9 · DOI
  108. Racine, 1978, Kindling: The first decade, Neurosurgery, 3, 234, 10.1227/00006123-197809000-00018 · DOI · Paper page
  109. Rathlev, 1994, The lack of efficacy of phenytoin in the prevention of recurrent alcohol withdrawal seizures, Ann Emerg Med, 23, 513, 10.1016/S0196-0644(94)70070-2 · DOI
  110. Ritson, 1986, Comparison of two benzodiazepines in the treatment of alcohol withdrawal: Effects on symptoms and cognitive recovery, Drug Alcohol Depend, 18, 329, 10.1016/0376-8716(86)90095-5 · DOI
  111. Rosenfeld, 1961, A controlled study of alcohol withdrawal, Q J Stud Alcohol, 1, 77, 10.15288/qjsas.1961.s1.077 · DOI
  112. Ryzen, 1985, Magnesium deficiency in a medical ICU population, Crit Care Med, 13, 19, 10.1097/00003246-198501000-00006 · DOI · Paper page
  113. Saitz, 1995, Recognition and management of occult alcohol withdrawal, Hosp Pract, 30, 49, 10.1080/21548331.1995.11443214 · DOI
  114. Saitz, 1995, Alcohol withdrawal: A nationwide survey of inpatient treatment practices, J Gen Intern Med, 10, 479, 10.1007/BF02602395 · DOI
  115. Saitz, 1995, Clinical features associated with alcohol withdrawal duration [abstr], J Gen Intern Med, 10, 48
  116. Saitz, 1994, Individualized treatment for alcohol withdrawal: A randomized double-blind controlled trial, JAMA, 272, 519, 10.1001/jama.1994.03520070039035 · DOI · Paper page
  117. Sampliner, 1974, Diphenylhydantoin control of alcohol withdrawal seizures: Results of a controlled study, JAMA, 230, 1430, 10.1001/jama.1974.03240100048028 · DOI
  118. Sellers, 1983, Diazepam loading: Simplified treatment of alcohol withdrawal, Clin Pharmacol Ther, 34, 822, 10.1038/clpt.1983.256 · DOI · Paper page
  119. Sellers, 1981, Drugs to decrease alcohol consumption, N Engl J Med, 305, 1255, 10.1056/NEJM198111193052105 · DOI
  120. Sellers, 1994, Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence, Alcohol Clin Exp Res, 18, 879, 10.1111/j.1530-0277.1994.tb00054.x · DOI · Paper page
  121. Sereny, 1965, Comparative clinical evaluation of chlordiazepoxide and promazine in treatment of alcohol withdrawal syndrome, BMJ, 1, 92, 10.1136/bmj.1.5427.92 · DOI · Paper page
  122. Shaw, 1987, Tiapride in the long-term management of alcoholics of anxious or depressive temperament, Br J Psychiatry, 150, 164, 10.1192/bjp.150.2.164 · doi:10.1192/bjp.150.2.164
  123. Shaw, 1981, Development of optimal treatment tactics for alcohol withdrawal: I. Assessment and effectiveness of supportive care, J Clin Psychopharmacol, 1, 382, 10.1097/00004714-198111000-00006 · DOI · Paper page
  124. Solomon, 1983, Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome, Clin Ther, 6, 52
  125. Soyka, 1989, Epileptic seizures and alcohol withdrawal: Significance of additional use (and misuse) of drugs and electroencephalographic findings, J Epilepsy, 2, 109, 10.1016/0896-6974(89)90046-7 · DOI
  126. Sparadeo, 1982, Evaluation of a social-setting detoxification program, J Stud Alcohol, 43, 1124, 10.15288/jsa.1982.43.1124 · DOI
  127. Sternebring, 1983, Reduction in early alcohol abstinence fits by administration of carbamazepine syrup instead of tablets, Eur J Clin Pharmacol, 24, 611, 10.1007/BF00542209 · doi:10.1007/bf00542209
  128. Stockwell, 1991, Home detoxification from alcohol: Its safety and efficacy in comparison with inpatient care, Alcohol Alcohol, 26, 645, 10.1093/oxfordjournals.alcalc.a045169 · DOI
  129. Stockwell, 1983, The severity of alcohol dependence questionnaire: Its use, reliability and validity, Br J Addic, 78, 145, 10.1111/j.1360-0443.1983.tb05502.x · DOI · Paper page
  130. Stuppaeck, 1992, Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: A double blind study, Alcohol Alcohol, 27, 153
  131. Sullivan, 1991, Benzodiazepine requirements during alcohol withdrawal syndrome: Clinical implications of using a standardized withdrawal scale, J Clin Psychopharmacol, 11, 291, 10.1097/00004714-199110000-00003 · DOI · Paper page
  132. Thompson, 1975, Diazepam and paraldehyde for treatment of severe delirium tremens: A controlled trial, Ann Intern Med, 82, 175, 10.7326/0003-4819-82-2-175 · DOI · Paper page
  133. Thorp, 1995, Management of drug dependency, overdose, and withdrawal in the obstetric patient, Obstet Gynecol Clin North Am, 22, 131, 10.1016/S0889-8545(21)00559-3 · DOI
  134. Tsai, 1995, The glutamatergic basis of human alcoholism, Am J Psychiatry, 152, 332, 10.1176/ajp.152.3.332 · DOI · Paper page
  135. Umbricht-Schneiter, 1991, Alcohol abuse: Comparison of two methods for assessing prevalence and associated morbidity in hospitalized patients, Am J Med, 91, 110, 10.1016/0002-9343(91)90002-F · DOI
  136. Victor, 1953, The effect of alcohol on the nervous system, Res Publ Assoc Res Nerv Ment Dis, 32, 526
  137. Victor, 1967, The role of abstinence in the genesis of alcoholic epilepsy, Epilepsia, 8, 1, 10.1111/j.1528-1157.1967.tb03815.x · DOI · Paper page
  138. Vinson, 1991, Admission alcohol level: A predictor of the course of alcohol withdrawal, J Fam Pract, 33, 161
  139. Volpicelli, 1995, Naltrexone in the treatment of alcoholism: Predicting response to naltrexone, J Clin Psychiatry, 56, 39
  140. Wartenberg, 1990, Detoxification of alcoholics: Improving care by symptom-triggered sedation, Alcohol Clin Exp Res, 14, 71, 10.1111/j.1530-0277.1990.tb00449.x · DOI
  141. Wetterling, 1994, Clinical predictors of alcohol withdrawal delirium, Alcohol Clin Exp Res, 18, 1100, 10.1111/j.1530-0277.1994.tb00087.x · DOI
  142. Whang, 1985, Magnesium depletion as a cause of refractory potassium repletion, Arch Intern Med, 145, 1686, 10.1001/archinte.1985.00360090162024 · doi:10.1001/archinte.1985.00360090162024
  143. Whitfield, 1978, Detoxification of 1024 alcoholic patients without psychoactive drugs, JAMA, 239, 1409, 10.1001/jama.1978.03280410051018 · DOI · Paper page
  144. Whitworth, 1996, Comparison of alcamprosate and placebo in long-term treatment of alcohol dependence, Lancet, 347, 1438, 10.1016/S0140-6736(96)91682-7 · DOI · Paper page
  145. Williams, 1984, Alcoholic hypoglycemia and ketoacidosis, Med Clin North Am, 68, 33, 10.1016/S0025-7125(16)31239-1 · DOI · Paper page
  146. Wilson, 1984, A double-blind, placebo-controlled trial of magnesium sulfate in the ethanol withdrawal syndrome, Alcohol Clin Exp Res, 8, 542, 10.1111/j.1530-0277.1984.tb05726.x · DOI · Paper page
  147. Wilson, 1985, Double-blind trial of alprazolam and chlordiazepoxide in the management of the acute ethanol withdrawal syndrome, Alcohol Clin Exp Res, 9, 23, 10.1111/j.1530-0277.1985.tb05043.x · DOI · Paper page
  148. Wrenn, 1989, A toxicity study of parenteral thiamine hydrochloride, Ann Emerg Med, 18, 867, 10.1016/S0196-0644(89)80215-X · DOI
  149. Zeise, 1993, Acamprosate (calcium acetylhomotaurinate) decreases postsynaptic potentials in the rate neocortex: Possible involvement of excitatory amino acid receptors, Eur J Pharmacol, 231, 47, 10.1016/0014-2999(93)90682-8 · DOI · Paper page
  150. Zilm, 1980, Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal, Alcohol Clin Exp Res, 4, 400, 10.1111/j.1530-0277.1980.tb04839.x · DOI · Paper page

Cited by

See all 129

Metadata

Authors
Saitz, R., & O'Malley, S. S.
Venue
Medical Clinics of North America
Publisher
Elsevier BV
Published
1997-07
Volume
81
Issue
4
Pages
881-907
ISSN
0025-7125 (ISSN-L)
OpenAlex
W106360673
Cited by
129
References
8
FWCI
4.77
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PHARMACOTHERAPIES FOR ALCOHOL ABUSE. https://app.cochat.ai/papers/10.1016/s0025-7125(05)70554-x
The paper
Saitz, R., & O'Malley, S. S. (1997). PHARMACOTHERAPIES FOR ALCOHOL ABUSE. Medical Clinics of North America. https://doi.org/10.1016/s0025-7125(05)70554-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.